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Abstract
Optogenetic gene expression systems can control transcription with spatial and temporal detail
unequaled with traditional inducible promoter systems. However, current eukaryotic light-gated
transcription systems are limited by toxicity, dynamic range, or slow activation/deactivation. Here
we present an optogenetic gene expression system that addresses these shortcomings and
demonstrate its broad utility. Our approach utilizes an engineered version of EL222, a bacterial
Light-Oxygen-Voltage (LOV) protein that binds DNA when illuminated with blue light. The
system has a large (>100-fold) dynamic range of protein expression, rapid activation (< 10 s) and
deactivation kinetics (< 50 s), and a highly linear response to light. With this system, we achieve
light-gated transcription in several mammalian cell lines and intact zebrafish embryos with
minimal basal gene activation and toxicity. Our approach provides a powerful new tool for
optogenetic control of gene expression in space and time.
Essential for many applications in biomedical research, inducible promoter systems enable
the artificial control of gene transcription in eukaryotic cells1,2. While many of these tools
are widely useful, their reliance on small molecule inducers (e.g. doxycycline) limits their
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utility when precisely timed or localized induction is desired. Once applied, chemical
inducers are also limited by their rate of diffusion (slowing activation), difficult removal
(slowing deactivation), and potential off-target effects on normal cellular function. In
contrast, light is a rapid and nontoxic stimulus that naturally regulates many different
cellular processes in diverse settings3. To take advantage of these favorable properties, a
variety of natural photosensitive proteins have recently been engineered into light-controlled
transcriptional activators4–11, providing the potential to regulate gene expression with
previously unattainable spatiotemporal control. Nevertheless, these systems have significant
drawbacks that limit their use in a wide range of experiments. These disadvantages include
toxicity12, low levels of transcriptional activation (< 20-fold)4–8,11, long deactivation times
(> 2 hr)10, use of exotic chromophores not found in vertebrates4,5, potential interference of
the active photoreceptor with endogenous signaling pathways8, and the need for multiple
protein components4,6,7,9,11.
To address these limitations, we developed a new inducible promoter system using the
EL222 bacterial transcription factor13, which only contains the minimal elements needed for
light-dependent transcriptional activation: a photosensory LOV14 domain and a Helix-Turn-
Helix (HTH) DNA-binding domain. In the dark, the LOV domain binds the HTH domain,
covering the HTH 4α helix essential to dimerization and DNA binding13. Blue light
illumination (450 nm) triggers the photochemical formation of a protein/flavin adduct within
the LOV domain, disrupting inhibitory LOV/HTH interactions and allowing EL222 to
dimerize and bind DNA15,16. These structural changes spontaneously reverse in the dark,
rapidly inactivating EL222 (τ ~11 s at 37°C17). Within the native Erythrobacter litoralis
HTCC2594 host, we observed light-dependent activation of genes adjacent to genomic
EL222-binding sites, implicating this protein as a photosensitive transcription factor15.
Our mechanistic understanding of EL222 paves the way for its use in a single-protein
component system for light-dependent gene activation. Here we report that a minimally-
engineered variant of EL222 activates transcription in different eukaryotic systems upon
stimulation with moderate levels of blue light. With this method, we demonstrate over 200-
fold upregulation of gene expression from an EL222-responsive luciferase reporter in 293T
cells illuminated with levels of blue light compatible with robust cellular growth. In contrast,
dark-state and red light controls show < 2-fold changes, establishing minimal leakiness
under non-inducing conditions. Our system has rapid activation (< 10 s) and deactivation
kinetics (< 50 s), which compare favorably to the > 2 hr turn-off kinetics of a recently
developed LOV-based transcriptional system10. Furthermore, our system can achieve
functional regulation of cellular processes, as we demonstrate for light-gated regulation of
splicing in T-cells. Finally, we demonstrate that EL222 can be used for either global or
tissue-specific light-dependent gene expression in zebrafish with minimal toxicity,
expanding the repertoire of this expression system. Taken together, our data highlight the
broad utility of the EL222 system and its strengths as an optogenetic tool.
RESULTS
Development of an inducible promoter system based on EL222
EL222, a small (222 residue) bacterial transcription factor, is the basis of our engineered
expression system (Fig. 1a). Two N-terminal additions adapt this protein for eukaryotic
applications: a VP16 transcriptional activation domain (AD)18 and a nuclear localization
signal (NLS) sequence (Fig. 1a). Immunoblot analysis confirmed that the resulting VP-
EL222 fusion protein was expressed in 293T cells and distributed between the nucleus and
cytoplasm (Supplementary Results, Supplementary Fig. 1a).
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To test the potency of the VP-EL222 transactivator system, we constructed a reporter vector
containing the firefly luciferase (Fluc) gene under the control of five copies of the EL222-
binding Clone 1–20 bp (C120)15 sequence and a TATA box promoter (pC120-Fluc) (Fig.
1a). In transient transfections, 293T cells expressing VP-EL222 showed elevated levels of
luciferase with pulsed blue light illumination (24 hr of 20 s on, 60 s off cycles; 8 W/m2 at
465 nm) compared to dark-state control cells (Fig. 1b). The light-driven upregulation of
luciferase levels required EL222, since transfection of a vector containing only the VP16
AD (empty vector) showed effectively no activation of the pC120-Fluc reporter in any
condition. Importantly, the luciferase levels observed between cells expressing VP16 AD
alone and the dark-state VP-EL222 cells are similar, establishing that VP-EL222 protein has
minimal dark-state activity (as seen with in vitro DNA binding assays13,15) and attributing
background levels to basal activation of the reporter construct itself.
To quantify the transcriptional fold change (FC) of pC120-Fluc, we normalized the firefly
luciferase values to an internal vector control (co-transfected with pVP-EL222 and pC120-
Fluc) which used the constitutive CMV promoter to drive expression of Renilla luciferase
(Rluc). We calculated that cells transfected with VP-EL222 showed 216-fold upregulation
of luciferase relative to cells transfected with empty vector when illuminated with blue light
(Supplementary Fig. 1b). In contrast, cells kept in the dark showed only a two-fold change,
as expected from the low affinity of EL222 for DNA in the dark13,15. Taken together, these
results demonstrate a net 108-fold increase in luciferase expression arising directly from
illumination.
For maximum utility, specificity in inducible promoter systems is essential – both with
target DNA sequences and with input stimuli – to avoid off-target effects. For the former,
we previously investigated the in vitro specificity of EL222 with variants of the C120 DNA,
showing that single basepair changes reduce EL222/DNA affinity over ten-fold15. Here we
show that VP-EL222 retains its selectivity for C120 DNA in 293T cells, as measured by the
increased expression from the pC120-Fluc reporter compared to two control constructs (Fig.
1c, Supplementary Fig. 1c). The first control contains three copies of a lower affinity EL222
substrate called AN4513 (p(AN45)3-Fluc), which binds EL222 approximately 30-fold more
weakly than C12013,15. A second control contained five copies of the GAL4-binding
Upstream Activation Sequence (UAS) (p(UAS)5-Fluc). In both cases, luciferase levels were
low and invariant to illumination when co-transfected with pVP-EL222. Critically,
expression levels from the two control vectors are comparable to those from pC120-Fluc
when VP-EL222 is present and kept in the dark. This demonstrates that the measured
leakiness in our experiments arises from basal transcription from the minimal promoter and
not spurious dark activation of VP-EL222 or by binding of any cellular factors to the C120
promoter. Lastly, we underscore that the minimal promoter and UAS sequences used here
were obtained from commercial sources that have previously evaluated their background
activity19,20, establishing our VP-EL222/C120 as having comparable background as these
widely-used reagents.
Additional experiments confirmed that expression of pVP-EL222 in 293T cells did not
significantly affect cell viability as compared to the pVP-empty control under both dark and
light conditions (Supplementary Fig. 2a), suggesting that neither VP-EL222 itself, VP-
EL222 driven transcription, nor our illumination protocol generate any gross toxicity.
Lastly, we found that VP-EL222 is not triggered by continuous red light, as luciferase levels
from the pC120-Fluc reporter are comparable under dark and red light conditions
(Supplementary Fig. 2b,c). This indicates that VP-EL222 is specifically activated by blue
light, consistent with standard LOV photochemistry. Together these data demonstrate that
the functional and photochemical properties inherent to EL222 are suitable for use in
heterologous expression in mammalian cells.
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Characterization of VP-EL222 in stably transfected cells
To reduce experimental variability caused by differential transfection efficiencies, we stably
expressed VP-EL222 in 293T cells and transfected only the pC120-FLuc plasmid (Fig. 1b,
Supplementary Fig. 1b). As a control, wild-type 293T cells (without VP-EL222) were also
transfected with pC120-Fluc alone. Consistent with our pVP-EL222 transient transfection
data, luciferase levels were greatly enhanced in stable VP-EL222 cells illuminated with blue
light relative to cells left in the dark (162-fold dark-to-light enhancement after 12 hr
illumination with 20 s on, 60 s off cycle). Furthermore, we again observed that luciferase
levels in VP-EL222-expressing cells kept in the dark were comparable to those measured
from wild-type 293T cells in both conditions. These results establish that the VP-EL222
system can generate high reporter gene expression in both transient and stable transfection
experiments and that dark-state leakiness stems from basal activation of the pC120-Fluc
vector itself.
A key advantage of a light-switchable promoter system is the ease of tuning gene expression
levels by modifying illumination protocols. We investigated the effects of modifying one
such parameter – the duration of the on/off duty cycle – by examining luciferase expression
off the pC120-Fluc reporter in the VP-EL222 stable cell line (Fig. 2a). Within a constant 80
s period, we observed an expected dose-dependent increase in luciferase with increasing
duration of illumination during each cycle, with a linear correlation between luciferase
levels and illumination times for periods of 5 s or greater. In addition to producing luciferase
at levels easily quantitated by enzymatic output, VP-EL222 is capable of expressing proteins
at levels sufficient to be detected by Western blot (luciferase, Supplementary Fig. 3) or
fluorescence microscopy (mCherry, Fig. 2b). In both cases, signals were detectable only in
the presence of VP-EL222 and following blue light illumination.
Turning from steady-state measurements to the kinetics of gene expression, we examined
protein and mRNA levels as a function of illumination time. To do so, we measured the
luciferase activities of VP-EL222-expressing cells transfected with pC120-Fluc and
incubated in the dark or illuminated with a 20 s on, 60 s off protocol for the indicated times
(Fig. 2c). As a control, luciferase levels were also measured in wild-type 293T cells
transfected with pC120-Fluc and illuminated with blue light pulses. We observed that
luciferase activity was rapidly induced, with 80-fold increases observed over VP-EL222
dark-state control after only 3 hr. Induction levels further increased slightly to around 90-
fold by 6 hr, and plateaued after 9 hr at 100-fold. Interestingly, luciferase activity began to
drop slightly between 12–24 hr; nevertheless, after 24 hr luciferase expression remained >
20-fold above background. While we detected a time-dependent increase in luciferase
activity in dark VP-EL222 cells, this was virtually identical to 293T control values and
significantly lower than from comparable illuminated VP-EL222 cells (Fig. 2c, p < 0.0001).
In parallel, we measured luciferase mRNA levels using qPCR (Fig. 2d), quantitating the
relative expression level in each sample with a normalized cycle threshold value (ΔCT) (ΔCT
= CT Fluc - CT GAPDH). As expected, the ΔCT values for light-treated VP-EL222 sample
were smaller than those measured for dark VP-EL222 and light-treated 293T samples. These
ΔCT values were used to calculate luciferase mRNA fold changes in VP-EL222 dark and
light-treated samples relative to the light-treated 293T control. These analyses showed that
luciferase mRNA spiked after 3 hr of illumination, maximizing after at 6 hr (Fig. 2d inset; ~
16-fold increase over 293T control). After 9 hr of illumination, luciferase mRNA levels
decreased to 9-fold over 293T control, before falling to < 2-fold up at 24 hr. We note that
these trends in luciferase transcript levels precede the corresponding trend in protein levels
(Fig. 2d). These data suggest a loss of VP-EL222 transcriptional activity during extended
illumination, potentially due to a moderate decrease in VP-EL222 protein levels
(Supplementary Fig. 3).
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This time-dependent decrease led us to ask if VP-EL222 could be reactivated after an initial
round of illumination followed by a dark recovery period to allow for synthesis of fresh
transcription factor. To do so, we monitored luciferase activity in wild-type 293T and stable
VP-EL222 cells (both transfected with pC120-Fluc) that were initially illuminated with blue
light (20 s on, 60 s off) for 3 hr, incubated in the dark for 21 hr, then again illuminated for 3
hr (Fig. 2e). After the initial activation, luciferase levels elevated approximately 75-fold over
dark control VP-EL222 cells. Once the light was removed, the absolute amount of luciferase
activity remained elevated in the illuminated cells; however, luciferase background levels
slowly increased in the dark control VP-EL222 cells, dropping the dark-to-light fold
induction to near background levels over 21 hr (< 1.5-fold difference dark-to-light). After
this recovery period, cells were illuminated for 3 hr with pulsing blue light, increasing
luciferase levels back up to 11-fold over VP-EL222 dark-state controls. Following another
21 hr dark recovery period, luciferase induction decreased to around 3.7-fold. Critically,
similar luciferase levels were seen in dark control VP-EL222 cells and illuminated wild-type
293T cells throughout, as observed previously. Therefore, the data show that light-triggered
activation of VP-EL222 can generate multiple rounds of gene expression, enabling novel
experiments utilizing transient increases of protein level.
Modeling transcriptional kinetics of VP-EL222 in cells
Aspects of these applications – linear dose-response (Fig. 2a) and favorable kinetic
properties (Fig. 2e) – are enabled by the intrinsically fast activation and deactivation kinetics
of EL222. In vitro measurements reveal LOV domains activate via microsecond-to-
millisecond timescale events21,22, while deactivation by adduct cleavage occurs over
seconds to hours17,23. Comparable activation/deactivation measurements for VP-EL222
driven transcription within cells are complicated by slow reporter mRNA and protein
turnover (e.g. luciferase mRNA half-life: 3–5 hr24,25, protein: 3–4 hr26), limiting the
temporal resolution of many experiments that yield this information. As an alternative, we
developed a kinetic model that correlates gene expression with the times required for VP-
EL222 to initiate transcription upon illumination (τon) or cease in the dark (τoff) (Fig. 3a;
Supplementary Notes 1, 2). This model lets us obtain information on second-timescale
events from final end-point measurements of luciferase levels accumulated from repeatedly
activating VP-EL222, each time gaining a burst of mRNA (Fig. 2a).
Coupled with an accompanying least-squared error analysis (Fig. 3b), this framework lets us
determine how consistent different combinations of τon and τoff values are with our
experimental measurements. For activation, the observed lag in luciferase expression at
short illumination times implies an initial τon delay of approximately several seconds for
VP-EL222 to activate, bind DNA and initiate transcription. Our model exhibits an expected
inverse relationship between gene expression and τon, with values near 5 s recapitulating our
data most accurately (Fig. 3c). On deactivation, our model recapitulates a direct link
between τoff and luciferase levels, with optimal τoff values of approximately 30 s (Fig. 3d).
A more complete grid search of all values of τon and τoff reveals a range of values
compatible with our data (Fig. 3e). This range includes activation times of approximately 3–
5 s, compatible with single molecule measurements of transcriptional initiation rates27 and
the high level of VP-EL222 within 293T cells. The same analysis indicates τoff values
between 10–40 s; the shortest of these delays is consistent with our in vitro measurements of
EL222 adduct cleavage (τadduct ~ 11 s at 37°C17), suggesting that cellular factors have
limited effects on this critical step. Taken together, these data suggest that VP-EL222
functions with rapid on/off kinetics in cells, a key advantage over other comparable
systems10.
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Light-inducible expression of CELF2 protein in T-cells
To test the utility of the VP-EL222 system in other cultured cell lines, we investigated its
ability to drive the expression of a functionally-active protein within the T-cell derived
Jurkat splicing line 1 (JSL1) cell line28. The JSL1 cell line has been extensively used to
study changes in alternative pre-mRNA splicing that occur in response to T-cell
activation28–30. One protein implicated in such control is CUGBP and ETR-2 like factor 2
(CELF2)31, an RNA-binding protein with a known role in splicing regulation in JSL1 cells
and thymocytes following cellular stimulation32. Phorbol myristate acetate (PMA)-induced
activation of JSL1 cells increases CELF2 expression, promoting its binding to regulatory
sequences in target pre-mRNAs and affecting their processing32. Indeed, at high levels
CELF2 protein represses the inclusion of exon 6 in its own pre-mRNA29,32,33, providing an
assay to ascertain if the VP-EL222 system could drive CELF2 overexpression sufficiently to
confer light-dependent control of pre-mRNA splicing.
To examine this, we created a JSL1 cell line stably integrated with both the pVP-EL222
activator and a FLAG-tagged CELF2 under the control of the EL222-specific C120
promoter (VP-EL222/CELF2 cells). VP-EL222/CELF2 cells incubated in the dark showed
nearly no expression of FLAG-CELF2 protein by immunoblot analysis (Fig. 4a,
Supplementary Fig. 4a), while cells exposed to blue light for 24 hr (20 s on, 60 s off)
showed moderate FLAG-CELF2 expression indicating functional light-triggered activation
of VP-EL222 in JSL1 cells. Notably, the levels of VP-EL222 protein itself decreased
markedly (> 50%) with light exposure (Fig. 4a), more substantially than we observed with
293T cells (Fig. 2b). Nevertheless, the small amount of VP-EL222 is sufficient to produce
amounts of CELF2 protein readily detectable by Western blot.
To address the functional significance of light-induced FLAG-CELF2 upregulation, we
analyzed the splicing pattern of exon 6 of the endogenous CELF2 transcript by reverse
transcription-PCR (RT-PCR) analysis using primers that specifically recognize the
endogenous transcript and not the transfected cDNA. We found that blue light induced a
moderate, but statistically significant, increase in the skipping of the CELF2 exon 6 in VP-
EL222/CELF2 cells (p < 0.05, Fig. 4b, Supplementary Fig. 4b), demonstrating light-
regulated alternative splicing. Importantly, blue light treatment had no discernible effects on
exon 6 inclusion in wild-type JSL1 cells, underscoring the necessity of the photosensitive
VP-EL222 in this process. Previous studies determined that PMA stimulation of JSL1 cells
leads to a two-fold increase in CELF2 protein levels32, changing percent exon inclusion
values by 20–30%29. In our experiment, light increases the amount of FLAG-CELF2 protein
five-fold over dark control; however, this does not detectably increase total CELF2 levels as
seen by Western blot. This observation is consistent with known autoregulatory mechanisms
which maintain stable CELF2 expression32. In addition, the fact that induction of FLAG-
CELF2 only marginally increases overall CELF2 protein is consistent with the relative
effect we observed in CELF2 exon 6 skipping (20% to 25%).
VP-EL222 serves as a transcriptional activator in vivo
Transitioning from cell culture to intact multicellular organisms, we examined the capability
of VP-EL222 to drive light-triggered gene expression in the zebrafish (Danio rerio). To do
so, we microinjected the pC120-mCherry plasmid into zebrafish embryos at the one-cell
stage, with or without 50 pg VP-EL222 mRNA (Fig. 5a). When embryos microinjected with
VP-EL222 mRNA and pC120-mCherry were illuminated with constant blue light (14 mW/
m2), mCherry fluorescence was readily detected after only 5 hr (70% epiboly stage). After
22 hr illumination (24 hr post-fertilization [h.p.f.] stage), 100% of the 50 embryos analyzed
had marked mCherry fluorescence, the level of which is nicely illustrated by a z-stack series
of an embryo at 70% epiboly with VP-EL222 driven mCherry expression (Supplementary
Motta-Mena et al. Page 6













Video 1). In contrast, when VP-EL222/pC120-mCherry embryos were left in the dark or did
not receive VP-EL222 mRNA, no fluorescence was detected (0/50 embryos in each set;
Supplementary Video 2). These results show that VP-EL222 can rapidly and robustly
activate transcription in developing zebrafish in a light-dependent manner.
Complementing these embryo-wide expression studies, we examined the ability to use VP-
EL222 for light-inducible, tissue-specific gene expression. For this, we constructed a dual-
promoter plasmid encoding the VP-EL222 ORF controlled by the zebrafish cardiac myl7
(myosin light polypeptide 7) promoter34 and the mCherry ORF controlled by the EL222-
specific C120 promoter. Zebrafish embryos microinjected with pmyl7-VP-EL222/C120-
mCherry plasmid and illuminated with constant blue light, but not dark counterparts,
showed noticeable mCherry fluorescence that was specifically localized in the developing
heart (Fig. 5b; Supplementary Video 3).
Finally, we examined the toxicity of VP-EL222 in zebrafish embryos, comparing groups
that were illuminated after being titrated with different amounts of VP-EL222 or GFP
mRNA (Supplementary Fig. 5). We found that a small amount of VP-EL222 (50 pg mRNA)
was sufficient to elicit high levels of mCherry expression (Fig. 5a) with only minimal
morphological effects (81% unaffected embryos for VP-EL222 vs. 93% for GFP) or toxicity
(<10% severely affected or dead) when compared with comparable GFP controls. Increasing
amounts of microinjected VP-EL222 mRNA up to 150 pg affected more embryos, but these
effects (~60% embryos unaffected; [severely affected + dead] < 25%) remained constant
above this level. These results suggest that VP-EL222 protein is only moderately toxic to
zebrafish, much less than observed for a cryptochrome-based light-driven transcription
system12.
DISCUSSION
Here we describe a new inducible gene expression system that confers high-level, blue light-
sensitive control of transcriptional initiation to human cell lines and zebrafish embryos.
Using the naturally-occurring EL222 transcription factor13,15–17, we take advantage of LOV
domain photochemistry and subsequent conformational changes, as seen in other LOV
domains and the related Per-ARNT-Sim (PAS) sensors35,36.
More broadly, this system has several benefits compared with alternative photocontrolled
gene expression methods. First, VP-EL222 functions in a range of eukaryotic cell settings,
enabled by the use of widely-available flavin chromophores and thus eliminating the need to
supply exogenous cofactors or precursors4,5. Additionally, VP-EL222 has low toxicity
(Supplementary Fig. 2a) and basal transcriptional activity in cell lines and zebrafish (Fig. 1
and Fig. 5); both features may be related to the absence of intact C120 targets in the human
and zebrafish genomes (Supplementary Table 1). Second, the required VP-EL222
photochemistry is triggered with low intensity blue light (8 W/m2 = 0.008 mW/mm2), less
than required to activate channelrhodopsin-driven optogenetic applications (e.g. 5 mW/
mm2)37. Third, VP-EL222 uses only a single 33 kDa protein with a directly-regulated DNA
binding step, simplifying genetic manipulation and tuning compared to light-dependent two-
hybrid systems4,6,7,9,11 or those which must tie into existing cellular signaling pathways8.
Finally, VP-EL222 quickly activates and resets after illumination (Fig. 3e), facilitating
transient-expression experiments and predictable dose-response behavior.
A final characteristic of VP-EL222 that warrants explicit discussion is the background
expression under non-inducing conditions. This can arise from two sources: 1) residual dark
state binding of EL222 to C120 sites and 2) spurious activation of the minimal promoter
from the reporter vector itself. We consistently observed that pC120-Fluc alone produced
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similar activation levels as dark-state VP-EL222-expressing cells transfected with pC120-
Fluc (Fig. 1, Fig. 2), strongly suggesting that any basal activation comes primarily from
pC120-Fluc itself. Importantly, these background expression levels are equivalent to those
from a commercial GAL4-driven expression vector (Fig. 1c) containing widely-used
consensus UAS sites19. From a practical standpoint, it is also clear that any background
expression we observed with VP-EL222 had minimal effects among many different types of
experiments (Fig. 2b, Fig. 5a; Supplementary Fig. 3). We appreciate that some other
applications may be affected by this low background activation (e.g. overexpression of
certain enzymes); therefore, we present raw activity / abundance values in formats that most
clearly demonstrate background expression levels (Fig. 1, Fig. 2) to inform users of these
methods of potential contributions that may arise from this source. Finally, we also note that
promoter modifications may establish lower background expression levels, as demonstrated
in the optimization of Tet-responsive systems38.
Recently, a variety of light-inducible systems for regulating gene expression in mammalian
cells8,10 have been reported. Such systems fall roughly in two categories, based on their
regulation of a). DNA binding or b). recruitment of a TAD to a DNA-bound protein. The
first group is typified by a highly-modified version of the Vivid LOV protein, which can
strongly activate gene transcription (> 200-fold)10 albeit with somewhat non-ideal dose-
response behavior and deactivation kinetics due to a long-lived photoadduct (half-life = 2
hr). The second strategy is more widely used, with a flexible two-hybrid type
implementation involving TALE DNA-binding domains with a light-inducible CRY2/CIB
interaction to reversibly recruit a TAD39. While this system can be customized to target
many DNA sites, it also uses TALE domains constitutively bound to DNAs, potentially
altering endogenous protein/DNA interactions nearby. In contrast, the direct photocontrol of
VP-EL222 DNA binding minimizes such in the dark. While VP-EL222 is currently
restricted to one binding site, prior HTH engineering studies40 suggest that this could be
changed in VP-EL222 variants.
Looking ahead, we see many cell biology, synthetic biology and other applications of
artificial transcriptional regulators with different needs, such as maximum kinetic resolution
or sensitivity. Mechanism-based approaches – such as EL222 variants engineered with
shorter- and longer-lived photoactive states17 – will be essential to developing reagents
optimized for each of these applications. Such engineering is facilitated by correlations
between in vitro and cellular properties (e.g. deactivation times), enabling rapid and simple
screening of mutants. Coupled with the ability to control epigenetic or other cellular
machinery to specific DNA sites in a light-dependent manner with other VP-EL222 variants,
we anticipate that this protein will enable an even wider range of applications in the future.
ONLINE METHODS
Vector construction
DNA containing residues 14–222 of EL22213 was cloned into the pVP16 (Clontech) vector
to obtain pVP-EL222. The pVP-EL222-puro plasmid was created by PCR amplification of
VP16-EL222 ORF and cloning into pIRESpuro (Clontech). Five tandem copies of the 20-bp
Clone-1 (C120) sequence15 were chemically synthesized (GeneArt) and inserted into the
pGL4.23[luc2/minP] (Promega) to make pGL4-C120-Fluc. pcDNA-C120-Fluc was created
by PCR amplifying the C120 sequence and the firefly luciferase ORF from the pGL4-C120-
Fluc vector and cloning both into pcDNA3.1+ (Invitrogen). pGL4-C120-mCherry was
created by PCR amplification of mCherry ORF and sub-cloning into pGL4-C120-Fluc to
replace the luciferase ORF. The sequences and maps of the constructs used in this study are
provided in the supplementary information.
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Cell culture, transfections, light induction, and cell viability assay
293T (ATCC) and JSL1 cells were cultured at 37°C in 5% CO2 in DMEM (Thermo
Scientific) and RPMI (Gibco) respectively. Both did not contain phenol red and were
supplemented with 5–10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin
solution.
To make the 293T VP-EL222 stable cell line, cells were transfected with pVP-EL222-puro
plasmid and allowed to recover for 3 days. Afterwards, cells were serially diluted into
medium containing 2 μg/ml of puromycin (Gibco) and grown for 1–2 weeks. Puromycin-
resistant clones were expanded and analyzed for VP-EL222 expression by Western blotting.
To make a JSL1 VP-EL222 stable cell line cells were diluted in medium containing 0.2 mg/
ml zeocin (Gibco). The JSL1 VP-EL222/C120-FLAG-CELF2 double stable cell line was
made by transfecting the JSL1 VP-EL222 stable cell line with pC120-FLAG-CELF2
plasmid. After transfection, cells were diluted in medium containing 0.6 mg/ml G418 sulfate
(Gibco). Drug-resistant clones were screened by RT-PCR for genomic integration of the
pC120-FLAG-CELF2.
For transient transfections, 293Ts were plated at 2 × 105 cells/well in 24-well plates and
transfected with 0.5 μg pGL4.23-C120-Fluc DNA the same day using lipofectamine
(Invitrogen). pVP-EL222 or pVP-empty, pGL4-C120-Fluc, and pGL4.75[hRluc/CMV]
(Promega) constructs were transfected using 5 : 1 : 0.04 ratio, respectively. 24 hr post-
transfection, a blue LED panel (465 nm, 2501BU, LED Wholesalers) was placed above the
plate. The intensity of the light received by cells was measured to be 39.7 mol s−1 m−2
(equivalent to 8 W/m2) using the LI-190 Quantum Sensor and LI-250A light meter (LI-COR
Biosciences). The LED panel was connected to an electronic intervalometer (Model 451,
GraLab) and set to a cycle of 20 s on and 60 s off. The control plate was kept in the dark
throughout the experiment. 48 hr post-transfection, firefly and Renilla luciferase activities
were measured using the Dual-Glo luciferase assay kit (Promega) according to the
manufacturer’s instructions. The following equation was used to determine the normalized
fold change in transcription in the dark and with light between cells expressing pVP-EL222
and pVP-empty: FC = (Fluc/Rluc)VP-EL222/(Fluc/Rluc)empty.
For transfection of 293T VP-EL222 stable line, cells were plated one day before transfection
at 1 × 105 cells/ml in 24-well plates. The next day, 0.8 μg of pcDNA-C120-Fluc DNA were
transfected using lipofectamine. Immediately afterwards, the cells were illuminated using
LED panel (20 s on, 60 s off) for 12 hr, unless otherwise indicated in figure legend. For
experiments done with JSL1 cells, wild type or VP-EL222/C120-FLAG-CELF2 stable cells
were plated at 6 × 105 cells/well in 6-well plates. The next day, cells were illuminated (20 s
on, 60 s off) for 24 hr and subsequently harvested for Western and RT-PCR analysis.
Viability of 293T cells was evaluated using the Cell Titer Blue assay (Promega) according
to the manufacturer’s instructions.
Nuclear/cytoplasmic extract isolation and Western blotting
293T cells (5.4 × 106 cells total) were grown in 10 cm dishes and were transfected with
pVP-EL222 or left untreated. 48 hr post-transfection, nuclear and cytoplasmic extracts were
purified using the following protocol. Cells were harvested and pelleted by centrifugation
for 5 min at 3,220 × g. The pellet was resuspended in 1 ml of ice-cold PBS, centrifuged for 5
min at 100 × g, and resuspended in 1 ml ice-cold Buffer A (10 mM Tris-Cl pH 7.5, 1.5 mM
MgCl2, 10 mM KCl). The cell suspension was incubated on ice for 5 min, in a dry ice/
ethanol bath for 5 min, and in a 37°C water bath for 5 min. This incubation series was
repeated 2 more times. Afterwards, the cells were centrifuged at 4°C for 15 min at 15,900 ×
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g. The supernatant (nuclear extract) was moved to a new tube and the pellet (cytoplasmic
extract) was resuspended in 1 ml Buffer A.
For Western blotting, equal protein amounts of total cell lysates were separated on a 10%
Mini-PROTEAN TGX precast gel (BioRad) and then transferred to a polyvinylidene
fluoride (PVDF) membrane (Amersham). The protein signal was detected using the Pierce
ECL Western Blotting Substrate (Thermo Scientific) according to the manufacturer’s
instructions. The antibodies used were as follows: anti-VP16 AD (ab4808, Abcam), anti-
luciferase (L0159, Sigma), anti-β-actin (A5441, Sigma), anti-ARNT (sc-17811, Santa Cruz
Biotechnology), anti-hnRNP L (ab6106, Abcam), anti-FLAG (2368, Cell Signaling).
Pre-mRNA splicing analysis
RNA isolation and analysis of pre-mRNA splicing by RT-PCR were done as described
previously for JSL1 cells28,41. Primers for the analysis of the endogenous CELF2 gene are
as follows: forward primer in the 5′-UTR region, 5′-
TCTGCTCGACAGCAGCACGCAGTG-3′; reverse primer downstream of variable exon 6,
5′-CAGGTGGCAGTGTTGAGCTGC-3′.
Quantitative PCR (qPCR) analysis
Total RNA was isolated from transfected wild-type 293T and VP-EL222 cells using an
RNeasy kit (Qiagen) following the manufacturer’s instructions. 4 μg of total RNA were
treated with DNase I (NEB) to remove genomic DNA. 1 μg of each treated RNA sample
was reverse transcribed using iScript cDNA synthesis kit (BioRad). qPCR was performed on
a Applied Biosystems 7300 real-time PCR system using TaqMan Fast Advanced Master
Mix and TaqMan Gene Expression Assays for Luciferase and GAPDH (Applied
Biosystems) with 100 ng of cDNA as template. Samples were run in triplicate and the
average cycle threshold (CT) was calculated. The average luciferase CT value for each
sample was normalized to the corresponding average GAPDH CT value to obtain a ΔCT
value. The fold change in luciferase mRNA expression in VP-EL222 cells relative to wild-
type 293T samples was calculated using the comparative CT (ΔΔCT) method42.
Live cell fluorescence microscopy
Wild type or VP-EL222 stable 293T cells were transfected with pC120-mCherry plasmid,
immediately after the cells were illuminated for 24 hr (20 s on, 60 s off) or left in the dark.
Cells were examined on a Nikon Eclipse TS100 epifluorescence microscope running NIS
Elements and equipped with Photometrics Coolsnap HQ camera. Images were taken with a
10x/0.25 NA Achromat Ph1 objective and mCherry fluorescence was imaged with a G2A
filter. Image processing and analyses were performed using ImageJ software43.
Zebrafish strains
Adult zebrafish, both TL and AB wild-type strains, were maintained under standard
laboratory conditions44. Husbandry and experimental protocols for zebrafish studies were
approved by the International Animal Care and Use Committee.
Transient expression and light induction in zebrafish
Expression plasmid pCS2-VP-EL222 was created by PCR amplification of VP-EL222 ORF
and then cloned into pCS2+ (gift from Stephanie Woo). Capped messenger RNA was
synthesized using the mMESSAGE mMACHINE SP6 kit (Ambion). 50 pg of VP-EL222
mRNA and/or 20 pg of pGL4-C120-mCherry plasmid DNA were injected at the one-cell
stage. For heart-specific expression of VP-EL222 and light-induced induction of mCherry
reporter, VP-EL222 ORF and C120-mCherry promoter and ORF were PCR amplified and
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cloned into pminiTol2-myl745,46 to create the dual promoter construct, pminiTol2- myl7-VP-
EL222-C120-mCherry. 20 pg of pminiTol2-myl7-VP-EL222-C120-mCherry plasmid DNA
along with 50 pg of Tol2 transposase mRNA were injected at the one-cell stage.
Constant blue light was applied at approximately 2 h.p.f. with a blue LED panel (465 nm,
2501BU, LED Wholesalers). Actual power of light received by embryos was measured to be
~1 mW using a PM100D Laser Power and Energy Meter Console (Thorlabs). Dark controls
were placed in a lightproof box in the same 29°C incubator as light-treated samples. The
light was turned off at 24 h.p.f. for imaging and analysis of embryos. For heart specific
induction of mCherry, constant light was applied from 10 h.p.f. to 24 h.p.f.
Microscopy and image processing of zebrafish embryos
Fluorescent and brightfield images at 70% epiboly were taken on a Digital Scanned Laser
Light Sheet Microscope47. Embryos were mounted in a 1.5% low-melt agarose cylinder
using 3 mm O.D./2 mm I.D. FEP tubing (Bola). Z stacks of 2.58 μm intervals were taken
with a 10x/0.5 NA objective. mCherry fluorescence was imaged with 561 nm laser line and
a 561LP filter. Brightfield images were acquired using room light. Fluorescent and
brightfield images at 24 h.p.f. were taken on a Nikon Eclipse Ti microscope running NIS
Elements and equipped with a Lambda XL Broad Spectrum Light Source (Sutter) and an
iXon DU-897 EMCCD camera (Andor).
Dechorionated embryos were embedded in 1.5% low-melt agarose within glass-bottom Petri
dishes (MatTek Corporation). Whole embryo images were taken with a 4x/0.13 NA Plan-
Fluor objective and heart-specific images were taken with a 20x/0.75 NA Plan Apo
objective. Standard filter settings were applied. Image processing and analysis was
performed using ImageJ software43. For the 70% epiboly images, maximum intensity
projections of the fluorescent Z-stack were performed and merged with a corresponding
brightfield image. For whole embryo and heart-specific 24 h.p.f. images, mCherry and
brightfield channels were merged.
Toxicity curves in zebrafish
50, 100, 150, 200 or 300 pg of VP-EL222 or GFP (control) mRNA per embryo were
injected at the one- to two-cell stage. Unfertilized embryos were removed on day 0, and
phenotypes of each group were scored alongside uninjected control embryos from the same
clutch on day 1 after manual dechorionation. The experiment was performed under constant
blue light conditions (465 nm). Each group had at least n = 100 embryos. Embryos were
scored as follows: normal - unaffected, wild-type phenotype; mildly deformed - presence of
a slightly curved tail and/or mild edema; severely deformed - presence of smaller heads,
major curve or kink in tail, and/or severe edema.
Statistics
Data are represented as mean values ± s.d. For statistical analysis, a two-tailed Student’s t-
test was applied to test rejection of the null hypothesis. P values < 0.05 were considered
statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Model for the EL222-based light-inducible gene expression system
(a) Top, the VP-EL222 protein consists of the transcriptional activation domain from the
VP16 protein fused to EL222. In the dark VP-EL222 is unable to bind DNA; however,
exposure to blue light triggers a photochemical reaction between the LOV domain and its
flavin chromophore, which activates the attached HTH domain to bind DNA and turn on
gene transcription. Bottom, schematic representations of the DNA constructs used in this
work. (b) For transient transfections, cells were transfected with either empty vector
(containing only VP16 AD) or pVP-EL222 and pC120-Fluc plus an internal control plasmid
pCMV-Renilla. For stable transfections, cells stably expressing VP-EL222 protein and wild-
type 293T cells were transiently transfected with pC120-Fluc and pCMV-Renilla. Cells
were kept in the dark or illuminated with blue light pulses (465 nm; 20 s on, 60 s off; 8 W/
m2) for 24 hr (transient) or 12 hr (stable) (n = 3 independent experiments, each performed in
triplicate per condition ). (c) Cells were transiently transfected with either empty vector or
pVP-EL222 and one of three reporter constructs, pC120-Fluc, p(AN45)3-Fluc, or p(UAS)5-
Fluc and kept in the dark or illuminated with blue light pulses (465 nm; 20 s on, 60 s off; 8
W/m2) for 24 hr. Levels of luciferase activity are shown (one experiment performed in
triplicate per condition). ** P < 0.01; **** P < 0.0001 using two-tailed Student’s t-test. All
data are represented as mean ± s.d.
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Figure 2. Dose-dependent activation and photoreversibility of gene expression by VP-EL222
(a–e) Cells stably expressing VP-EL222 protein (VP-EL222 cells) and wild-type 293T cells
were transiently transfected with pC120-Fluc and were illuminated with blue light pulses
(20 s on, 60 s off) for 12 hr, unless otherwise indicated. (a) Luciferase activity levels in VP-
EL222 cells treated with blue light pulses of varying duration or kept in the dark. (b)
Representative images of VP-EL222 and wild-type 293T cells transfected with pC120-
mCherry and left in the dark or illuminated for 24 hr. Scale bar, 100 μm. (c) Luciferase
activity levels in wild-type 293T and VP-EL222 cells illuminated or kept in the dark for the
indicated times. (d) Luciferase mRNA levels quantified by qPCR from wild-type 293T and
VP-EL222 cells treated with blue light for indicated times or kept in the dark. Normalized
ΔCT (ΔCT = CT Fluc – CT GAPDH) values are shown. Inset shows fold change in luciferase
mRNA in VP-EL222 dark and light-treated samples relative to the light-treated 293T
control. (e) VP-EL222 and wild-type 293T cells were illuminated for two separate 3 hr
periods (white box) each separated by a 21 hr dark period (black box). Controls were kept in
the dark for the entire experiment. Luciferase activity levels were measured at the indicated
timepoints. (a–e, one experiment performed in triplicate per condition). *P < 0.05; ** P <
0.01; **** P < 0.0001 using two-tailed Student’s t-test. All data are represented as mean ±
s.d.
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Figure 3. Kinetic modeling of VP-EL222 activation
(a) Summary of the model used to describe VP-EL222 transcriptional activation, including
three phases of transcriptional activity. Additional details are provided in Online Methods.
(b) Data used for kinetic modeling (replotted showing mean ± s.d. from Fig. 2a) along with
definition of least squared error function. (c) Effect of varying τon on transcriptional activity.
For a given τoff of 30 s (estimated from in vitro measurements of EL222 deactivation17) and
Hill coefficient of 4, average steady-state transcriptional activities at τon values between 1–
50 s were calculated using our model. Best agreement with experimental data were obtained
with τon ~ 5 s. (d) Effect of varying τoff on transcriptional activity. For a given τon of 5 s
(based on panel c), average transcriptional activities at τoff values between 1–1000 s were
calculated. Best agreement with experimental error were obtained with τoff ~30 s. (e) Grid
search of τon, τoff values (independently iterated for τon < 100s, τoff < 100s), using the
model, data and error function described above. Heatmap indicates value of error function;
only the region with error function < 200 (τon 1–10s, τoff =1–100s) is shown here.
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Figure 4. Light-regulated gene expression of the splicing factor CELF2 using VP-EL222 in the
T-cell derived JSL1 cell line
(a) Western blot analysis of protein lysates derived from JSL1 cells stably expressing both
VP-EL222 and pC120-FLAG-CELF2 (JSL1 VP-EL222/CELF2 cells) were illuminated for
24 hr with either pulsing blue light (20 s on, 60 s off) or kept in the dark. An hnRNP L
antibody was used a loading control. (b) Percent skipping of exon 6 in endogenous CELF2
gene for wild type and VP-EL222/CELF2 JSL1 cells (VP-EL222) that were illuminated
with pulsing blue light (20 s on, 60 s off) for 24 hr or kept in the dark. The calculated exon
skipping in illuminated samples was normalized relative to that measured in dark samples
for each cell line. Below, representative RT-PCR gel showing the increase in exon skipping
relative to inclusion. (n = 2 independent experiments, each performed with one replicate per
condition). *P < 0.05 using two-tailed Student’s t-test. Data are represented as mean ± s.d.
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Figure 5. VP-EL222 robustly activates reporter gene expression in the developing zebrafish
embryo in a light-dependent manner
(a) Representative images of zebrafish embryos after injection with both VP-EL222 mRNA
and pC120-mCherry DNA or pC120-mCherry DNA alone. The embryos were kept in the
dark or illuminated with constant blue light for 5 hr (70% epiboly stage) or 22 hr (24 h.p.f.
stage) beginning at 2 h.p.f. (n = 50 embryos per condition). Each image is a maximum
intensity projection of a fluorescent Z-stack merged with its corresponding brightfield
image. Top scale bar, 100 μm; bottom scale bar, 300 μm. (b) Visualization of mCherry
fluorescence in the zebrafish heart in illuminated (as described above) versus control
embryos after injection with a dual promoter vector that contains VP-EL222 and mCherry
under the control of the cardiomyocyte-specific myl7 promoter and the EL222-specific C120
promoter; respectively. mCherry and brightfield channels were merged. Scale bar, 50 μm.
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